No definition available.
Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
C3_AML_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
351 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
351 |
4. Check minimum number of eventsNone |
351 |
5. Include endpoints |
351 |
6. Filter based on genotype QC (FinnGen only) |
351 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
- Control conditions
- not HLP_C3_AML
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia, helper endpoint
- Acute myeloid leukaemia
- Acute myeloid leukaemia and myelodysplastic syndromes
- Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 351 | 146 | 205 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 65.55 | 57.84 | 71.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 359
- Matched controls
- 3589
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
313
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
620.9
300.1
260
15
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
295.1
241
*
XW000
NOMESCO Finland
Bone marrow biopsy
110.8
193.3
202
41
WW500
NOMESCO Finland
Blood transfusion
64.4
124.0
142
36
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
75.5
108.6
121
24
A04AA01
ATC
ondansetron; systemic, rectal
74.6
94.9
106
20
127
Kela drug reimbursment
Transplant complication
97.6
77.0
83
11
L03AA02
ATC
filgrastim; parenteral
442.6
74.7
72
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
71.3
66
*
A05AA02
ATC
ursodeoxycholic acid; oral
94.3
69.2
75
10
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
65.7
61
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
64.6
60
*
J05AB11
ATC
valaciclovir; oral
10.1
57.1
126
182
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.3
54.3
91
73
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
52.4
49
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.7
46.9
124
231
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.4
43.5
116
216
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.1
43.4
83
87
R50.9
ICD-10 Finland
Fever, unspecified
6.7
42.7
126
269
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
40.4
38
*
JN4BD
NOMESCO Finland
Extensive body CT
13.2
40.2
73
68
J01MA12
ATC
levofloxacin; systemic
5.7
39.4
136
349
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
38.2
36
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
17.3
38.0
61
42
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
33.1
37.6
49
17
ZX120
NOMESCO Finland
Intravenous
8.1
36.0
87
136
J02AC03
ATC
voriconazole; systemic
382.7
35.6
35
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
57.6
35.3
41
8
Z51.5
ICD-10 Finland
Palliative care
19.2
34.5
53
32
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.6
33.9
60
52
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
31.1
33.3
44
16
L04AD01
ATC
ciclosporin; systemic
24.9
32.7
46
21
WW200
NOMESCO Finland
Immunization
19.2
32.6
50
30
N02AA05
ATC
oxycodone; systemic
6.3
32.4
95
193
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
353.7
32.4
32
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
31.7
30
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
11.1
31.1
61
65
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
29.6
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
29.1
209
1000
H02AB02
ATC
dexamethasone; systemic
29.0
29.1
39
15
ZX112
NOMESCO Finland
Subcutaneous
39.8
29.0
36
10
C61
ICD-10 Finland
Malignant neoplasm of prostate
304.0
28.2
28
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
108.8
28.1
30
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
25.6
28.1
39
17
D64.9
ICD-10 Finland
Anaemia, unspecified
5.1
27.6
97
241
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
27.4
26
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
26.4
25
*
L01BB02
ATC
mercaptopurine; oral
48.3
26.0
31
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
25.6
104
298
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
25.3
24
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
25.3
24
*
M04AA01
ATC
allopurinol; systemic
4.4
24.9
105
311
J02AC04
ATC
posaconazole; systemic
+∞
24.2
23
*
1DB06
NOMESCO Finland
NA
+∞
24.2
23
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
24.2
23
*
A41.9
ICD-10 Finland
Sepsis, unspecified
8.3
23.6
54
75
A04AA02
ATC
granisetron; systemic, transdermal
+∞
23.2
22
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
23.2
22
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
22.1
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
22.1
21
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.1
21
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.9
21.6
47
60
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
21.0
20
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
21.0
20
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
32.3
20.9
27
9
L04AA06
ATC
mycophenolic acid; systemic
24.1
20.7
29
13
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.7
20.4
35
28
J02AC01
ATC
fluconazole; systemic
3.0
20.2
159
749
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
20.0
19
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
20.0
19
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
20.0
19
*
B73
ICPC
Leukaemia
+∞
20.0
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
19.9
143
633
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
19.8
76
201
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
18.9
18
*
WW409
NOMESCO Finland
Other aferesis
+∞
18.9
18
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
200.0
18.7
19
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.1
18.1
41
56
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.4
18.1
24
9
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
2AX04
NOMESCO Finland
NA
188.9
17.7
18
*
TGC00
NOMESCO Finland
Bronchial lavation
9.3
16.9
35
41
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
94.5
16.7
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
31.7
16.3
21
7
A40.8
ICD-10 Finland
Other streptococcal sepsis
35.2
15.9
20
6
L01XX05
ATC
hydroxycarbamide; oral
20.4
15.8
23
12
1BC07
NOMESCO Finland
NA
+∞
15.7
15
*
116
Kela drug reimbursment
Prostate cancer
+∞
15.7
15
*
ZX121
NOMESCO Finland
Central venous catheter
89.1
15.7
17
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
89.1
15.7
17
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
89.1
15.7
17
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
15.6
136
658
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.4
15.5
34
44
J01MA14
ATC
moxifloxacin; systemic
4.3
15.2
59
156
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
26.3
14.8
20
8
JN4AD
NOMESCO Finland
Body CT examination
8.1
14.8
33
44
J05AB01
ATC
aciclovir; systemic
3.0
14.8
98
396
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
14.7
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.6
14.5
52
127
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
13.6
13
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
13.6
13
*
TPH00
NOMESCO Finland
Phlebotomy
35.6
13.6
17
5
R4110
NOMESCO Finland
Physiotherapy
2.6
13.1
115
548
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
17.6
13.1
20
12
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
13.0
101
450
D70.82
ICD-10 Finland
Drug-induced neutropenia
33.4
12.7
16
5
L02AE02
ATC
leuprorelin; implant, parenteral
25.4
12.6
17
7
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.6
12
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
12.6
12
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
134.5
12.5
13
*
C90.0
ICD-10 Finland
Multiple myeloma
134.5
12.5
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
12.4
97
430
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
11.5
11
*
L02BA01
ATC
tamoxifen; oral
123.8
11.5
12
*
1DB07
NOMESCO Finland
NA
123.8
11.5
12
*
H02AB09
ATC
hydrocortisone; systemic
8.1
11.4
25
33
212
Kela drug reimbursment
Gout
7.8
11.2
25
34
H02AB04
ATC
methylprednisolone; systemic
2.9
11.0
74
299
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
44.8
11.0
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.5
11.0
19
16
L04AA01
ATC
[U] ciclosporin; systemic
11.1
10.9
20
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
10.9
31
59
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
22.3
10.8
15
7
WF002
NOMESCO Finland
Radical radiotherapy
61.9
10.7
12
*
N05BA06
ATC
lorazepam; systemic, sublingual
4.6
10.6
36
84
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
10.5
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
10.5
106
537
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
10.1
43
124
A41.8
ICD-10 Finland
Other specified sepsis
8.5
10.0
21
26
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
10.0
9.9
19
20
5BA08
NOMESCO Finland
NA
26.9
9.9
13
5
HA1AA
NOMESCO Finland
X-ray mammography
8.2
9.8
21
27
TAB00
NOMESCO Finland
Lumbar puncture
4.9
9.5
30
65
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
9.5
36
94
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.5
9.4
27
52
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
9.4
9
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
9.1
88
431
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.0
8.9
18
21
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.1
8.9
16
15
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
8.8
141
863
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
8.8
24
44
J01MA02
ATC
ciprofloxacin; systemic
2.0
8.8
148
927
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
8.4
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.4
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
8.4
35
100
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
8.3
32
85
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
8.3
46
162
ZX108
NOMESCO Finland
Inhalation
17.7
8.1
12
7
L02BG04
ATC
letrozole; oral
17.7
8.1
12
7
ED1AA
NOMESCO Finland
Mandipular X-ray examination
34.2
8.1
10
*
A98
ICPC
Health maint/preventive medicine
0.5
7.8
232
2817
A07AA02
ATC
nystatin; oral
3.8
7.8
32
90
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
46.0
7.7
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
7.7
45
165
306
Kela drug reimbursment
Erythropoietin and darbepoetin
25.6
7.6
10
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
7.5
48
188
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.1
7.4
27
69
130
Kela drug reimbursment
Malignant tumour
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
7.3
7
*
2AX05
NOMESCO Finland
NA
+∞
7.3
7
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
7.2
36
119
A02BC02
ATC
pantoprazole; systemic
1.8
6.8
213
1610
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
40.8
6.8
8
*
SPAT1088
SPAT
Blood transfusion
17.1
6.8
10
6
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
6.7
42
161
RS220
NOMESCO Finland
NA
8.0
6.7
14
18
D64.8
ICD-10 Finland
Other specified anaemias
7.1
6.6
15
22
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.1
6.4
7
*
B02AA02
ATC
tranexamic acid; systemic
2.5
6.3
49
212
NK6AN
NOMESCO Finland
Total body bone isotope imaging
18.4
6.3
9
5
B02.9
ICD-10 Finland
Zoster without complication
3.4
6.3
29
91
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
1BC01
NOMESCO Finland
NA
+∞
6.3
6
*
1CX01
NOMESCO Finland
NA
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
6.3
6
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
+∞
6.3
6
*
N05CF01
ATC
zopiclone; oral
1.8
6.2
124
800
H02AB06
ATC
prednisolone; systemic
1.8
6.2
159
1114
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.1
6.2
33
115
B01AB05
ATC
enoxaparin; parenteral
1.9
6.2
97
574
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.0
161
1141
H02AB07
ATC
prednisone; oral
2.3
6.0
58
283
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
112
38
42.82
176.09
7.0
1.9
—
—
—
0
0
93
42
29.76
131.30
1.4
1.4
—
—
—
0
0
88
35
33.22
130.00
1.5
1.7
101.9
98.6
u/ml
—
24
7
85
40
27.72
117.66
1.4
1.5
243.6
174.8
u/ml
1.28
54
21
74
45
20.57
90.92
4.5
1.3
—
—
—
0
0
74
49
18.87
87.09
4.2
1.3
—
—
—
0
0
63
34
22.36
81.45
4.5
1.2
—
—
—
0
0
69
60
14.07
69.27
1.5
1.7
—
—
—
0
0
49
24
23.57
65.63
9.5
3.8
0.8
0.7
%
0.09
43
19
41
14
33.03
62.40
1.9
1.1
—
—
—
0
0
43
20
24.36
58.64
3.0
1.2
—
—
—
0
0
45
24
21.36
57.97
2.7
1.2
—
—
—
0
0
136
346
5.78
53.65
14.5
2.9
0.8
0.8
mmol/l
0.57
129
320
39
19
22.97
52.06
5.1
1.3
—
—
—
0
0
78
119
8.14
51.19
1.7
1.7
1.6
1.5
g/l
0.30
67
101
39
21
20.77
49.85
5.1
1.3
—
—
—
0
0
45
35
14.60
47.75
2.0
1.3
—
—
—
0
0
38
23
18.41
45.94
1.3
1.0
—
—
—
0
0
84
174
6.03
40.58
4.0
1.4
—
—
—
0
0
30
17
19.20
37.23
9.9
2.9
39.7
47.3
%
0.40
22
12
30
17
19.20
37.23
1.9
1.5
—
—
—
0
0
35
27
14.29
37.09
2.0
1.1
—
—
—
0
0
30
20
16.31
34.35
4.9
1.9
—
—
—
0
0
28
18
16.82
32.61
1.2
1.7
—
—
—
0
0
35
5
77.35
31.51
1.3
1.0
—
—
—
0
0
158
670
3.47
28.46
11.0
2.6
315.0
9246.2
umol/l
3.88
152
574
47
77
6.89
28.32
3.3
3.6
—
—
—
0
0
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
27
21
13.85
28.31
6.1
1.2
—
—
—
0
0
24
16
16.03
27.33
1.4
1.8
—
—
—
0
0
24
16
16.03
27.33
1.4
1.8
—
—
—
0
0
44
72
6.84
26.50
2.5
1.2
—
—
—
0
0
116
428
3.55
25.65
4.4
1.7
—
—
—
0
0
209
1117
3.15
24.46
25.4
5.5
33.1
27.2
%
6.86
203
1027
28
29
10.41
24.42
2.2
1.3
—
—
—
0
0
90
294
3.77
23.75
3.1
1.8
—
—
—
0
0
29
33
9.49
23.62
2.2
1.3
—
—
—
0
0
128
533
3.21
22.90
3.2
1.7
4.4
1.2
mg/l
2.44
115
400
23
21
11.65
21.77
1.3
1.1
—
—
—
0
0
87
296
3.58
21.43
3.0
1.7
—
—
—
0
0
26
8
34.94
20.49
7.2
3.0
—
—
—
0
0
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
19
14
14.29
20.37
7.7
1.1
—
—
—
0
0
196
1108
2.74
19.08
23.6
5.3
47.0
57.8
%
15.83
190
1021
19
16
12.50
18.84
1.1
1.1
—
—
—
0
0
16
10
16.72
18.61
1.1
1.0
—
—
—
0
0
120
541
2.85
17.98
15.6
2.0
—
—
—
0
0
182
1035
2.58
16.87
24.6
3.5
—
—
—
0
0
22
9
25.96
16.21
1.6
1.1
—
—
—
0
0
212
1317
2.54
15.98
57.1
6.2
2.9
4.3
e9/l
3.05
202
1144
21
28
7.91
14.99
7.1
1.8
33.2
34.4
pg
0.47
21
28
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
18
9
20.99
12.58
7.9
1.1
—
—
—
0
0
193
1236
2.25
12.40
21.6
5.5
1.2
1.2
mmol/l
0.23
167
1051
170
1040
2.23
12.16
20.1
3.7
32.4
35.4
g/l
7.92
164
954
179
1128
2.20
11.78
18.7
5.2
1.2
1.2
mmol/l
1.18
172
994
24
48
5.29
11.64
1.6
1.5
—
—
—
0
0
22
41
5.66
11.50
2.3
1.3
—
—
—
0
0
16
9
18.55
10.82
2.8
1.0
—
—
—
0
0
16
9
18.55
10.82
2.8
1.0
—
—
—
0
0
129
734
2.20
10.76
6.7
2.7
30.0
34.3
u/l
1.14
124
696
52
194
2.97
10.62
1.9
2.1
0.2
0.2
g/l
0.59
46
170
14
6
24.21
10.32
3.0
1.0
—
—
—
0
0
14
6
24.21
10.32
3.0
1.0
—
—
—
0
0
13
16
8.40
9.80
3.1
1.2
—
—
—
0
0
74
347
2.44
9.60
1.5
2.3
2.0
2.3
g/l
4.01
69
318
70
324
2.45
9.33
1.6
2.4
38.7
23.5
%
4.82
54
285
23
55
4.40
9.06
1.6
1.2
—
—
—
0
0
23
55
4.40
9.06
1.6
1.2
—
—
—
0
0
13
7
19.22
9.00
2.7
1.4
—
—
—
0
0
20
43
4.87
8.94
8.1
3.1
41.6
60.2
%
4.02
20
43
21
48
4.59
8.74
2.6
1.3
3.8
4.0
mmol/l
0.42
21
42
10
10
10.26
8.68
6.2
1.5
197.5
193.0
u/l
—
10
10
21
50
4.40
8.31
4.2
1.2
—
—
—
0
0
16
30
5.54
8.28
5.0
1.1
—
—
—
0
0
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
16
31
5.36
8.00
5.0
1.1
—
—
—
0
0
23
65
3.72
7.27
1.1
1.2
—
1.5
—
0
6
10
5
20.52
7.17
1.2
1.0
—
—
—
0
0
10
14
7.32
6.73
2.9
1.8
1224.6
715.0
u/ml
—
10
14
197
2443
0.56
6.51
4.7
5.2
2.6
2.6
mmol/l
0.01
184
2216
120
781
1.82
6.19
6.1
2.0
2.3
2.4
mmol/l
2.92
108
626
149
1036
1.76
6.13
4.3
2.6
860.9
127.6
ug/l
3.73
140
948
20
58
3.60
6.10
1.2
1.3
—
—
—
0
0
233
2742
0.55
6.06
88.2
19.5
3.7
4.5
e12/l
37.34
227
2646
233
2741
0.55
6.03
88.2
19.5
162.0
242.7
e9/l
21.82
227
2652
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
84
2.99
5.47
3.7
3.2
0.3
0.4
u/ml
0.29
12
49
30
119
2.66
5.45
7.3
1.5
—
—
—
0
0
193
2362
0.59
5.35
4.4
4.6
1.3
1.4
mmol/l
6.26
179
2143
9
8
11.50
5.32
1.8
1.4
—
—
—
0
0
9
8
11.50
5.32
3.0
1.1
—
—
—
0
0
9
8
11.50
5.32
3.0
1.1
—
—
—
0
0
186
2295
0.60
5.29
5.2
6.4
40.1
40.9
mmol/mol
0.64
171
2101
5
0
+∞
5.22
7.6
0.0
—
—
—
0
0
30
124
2.55
5.03
3.6
1.4
3.3
5.2
ug/l
0.32
25
91
36
163
2.35
4.98
1.6
1.4
—
—
—
0
0
15
41
3.78
4.98
1.1
1.1
—
—
—
0
0
198
2392
0.60
4.97
5.6
4.7
6.0
6.1
mmol/l
0.16
182
2137
103
678
1.73
4.95
2.3
2.1
2.7
3.1
mg/l
1.05
83
568
19
63
3.13
4.75
1.2
1.3
—
—
—
0
0
9
11
8.36
4.58
3.0
1.1
—
—
—
0
0
200
2385
0.62
4.39
5.0
4.6
4.3
4.5
mmol/l
1.12
188
2172
83
533
1.73
4.29
4.8
3.9
96.3
353.5
ng/l
1.27
74
439
36
174
2.19
4.29
9.4
6.6
24.8
24.8
mmol/l
0.01
36
164
126
904
1.61
4.26
5.4
3.0
—
—
—
0
0
190
2285
0.63
4.25
50.9
12.0
79.4
76.7
ml/min/173m2
0.83
161
1843
227
2614
0.63
4.03
43.6
8.9
29.0
25.0
u/l
3.18
220
2487
191
2277
0.65
3.89
5.5
4.5
1.9
2.0
mu/l
0.04
178
2038
8
11
7.41
3.88
1.4
1.2
—
—
—
0
0
25
108
2.42
3.86
3.2
1.4
—
—
—
0
0
9
15
6.13
3.84
5.1
1.3
—
—
—
0
0
7
8
8.90
3.79
1.3
1.3
—
—
—
0
0
6
5
12.17
3.77
2.3
7.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
12
6.79
3.69
1.4
1.3
—
—
—
0
0
107
763
1.58
3.62
4.2
2.2
48.1
57.9
u/l
2.47
97
703
9
17
5.40
3.53
1.1
1.0
—
—
—
0
0
6
6
10.14
3.51
1.2
1.0
—
—
—
0
0
49
287
1.82
3.44
8.6
6.6
1.3
1.7
mmol/l
0.27
39
221
45
259
1.85
3.34
5.0
4.0
1.4
2.1
mmol/l
0.45
35
204
41
229
1.89
3.34
9.4
6.4
99.5
123.0
g/l
9.39
41
222
64
410
1.69
3.30
5.2
2.8
3.2
3.0
e6/l
0.04
37
229
41
232
1.87
3.21
2.0
1.8
410.4
365.0
nmol/l
0.88
41
211
196
2281
0.68
3.09
5.4
4.1
1.6
1.3
mmol/l
5.34
183
2055
229
2584
0.67
3.02
57.8
16.4
138.7
139.7
mmol/l
6.18
224
2492
23
108
2.21
2.98
1.4
1.2
—
—
—
0
0
85
600
1.55
2.95
1.9
1.7
1322.4
1166.8
nmol/l
0.69
76
451
6
9
6.76
2.88
1.3
1.0
—
—
—
0
0
6
9
6.76
2.88
1.2
1.0
—
—
—
0
0
17
74
2.36
2.62
1.5
1.2
0.0
0.0
g/l
0.00
17
69
9
25
3.67
2.59
4.7
4.7
—
—
—
0
0
5
7
7.23
2.55
1.6
5.6
110.6
90.0
%
—
5
7
29
159
1.90
2.52
3.2
1.6
—
—
—
0
0
29
489
0.56
2.41
1.3
1.2
0.8
1.5
u/ml
—
6
131
17
77
2.27
2.41
1.5
1.2
0.0
0.0
g/l
0.00
17
70
6
12
5.07
2.41
1.2
1.1
13.2
15.8
u/l
—
6
12
94
705
1.46
2.40
5.5
2.9
0.3
0.5
e6/l
0.36
73
525
156
1846
0.72
2.37
5.0
3.7
14.8
14.9
pmol/l
0.31
144
1653
5
9
5.62
2.22
1.2
1.1
—
—
—
0
0
5
9
5.62
2.22
1.2
1.1
—
—
—
0
0
17
81
2.15
2.16
1.3
1.2
—
—
—
0
0
9
208
0.42
2.15
2.2
2.2
—
—
—
0
0
62
438
1.50
2.13
5.2
2.6
1.5
1.1
e6/l
0.16
36
258
17
82
2.13
2.10
1.5
1.2
0.0
0.1
g/l
0.49
17
75
17
82
2.13
2.10
1.3
1.2
—
—
—
0
0
9
32
2.86
2.01
1.1
1.8
—
—
—
0
0
8
188
0.41
1.99
2.4
2.0
—
—
—
0
0
12
51
2.40
1.97
1.0
1.1
—
—
—
0
0
11
45
2.49
1.95
1.2
1.4
—
—
—
0
0
5
11
4.59
1.94
2.0
2.3
25.6
26.3
umol/l
—
5
11
5
11
4.59
1.94
1.6
1.3
14.7
11.7
ug/l
—
5
11
189
1639
1.33
1.91
6.6
4.5
320.1
3995.7
e6/l
—
7
29
137
1148
1.32
1.71
2.2
2.1
85.6
93.4
pmol/l
1.36
100
575
198
2202
0.77
1.64
62.1
14.6
33.2
39.8
%
13.32
124
1487
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
6
21
2.89
1.51
1.0
1.2
—
—
—
0
0
21
124
1.74
1.51
6.6
5.1
25.0
24.8
mmol/l
0.11
21
117
76
947
0.75
1.44
4.5
3.9
2.3
2.1
ug/l
0.29
68
835
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
6
22
2.76
1.44
1.0
1.1
—
—
—
0
0
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
230
2492
0.78
1.43
70.0
13.3
36.7
24.2
mg/l
4.92
218
1948
57
741
0.72
1.43
4.3
3.8
20.1
24.8
%
1.20
28
360
5
17
2.97
1.36
1.2
1.1
368.6
303.8
u/l
—
5
17
8
157
0.50
1.28
3.1
1.7
—
—
—
0
0
23
148
1.59
1.23
2.1
2.4
1.3
0.2
e6/l
0.51
23
143
122
1406
0.80
1.22
3.6
2.8
—
—
—
0
0
20
125
1.64
1.20
1.4
1.3
—
—
—
0
0
5
20
2.52
1.15
1.2
1.1
—
—
—
0
0
38
508
0.72
1.13
3.0
2.7
0.9
0.8
ug/l
0.18
24
359
7
32
2.21
1.08
1.0
1.1
—
—
—
0
0
11
59
1.89
1.08
2.0
1.7
109.8
135.1
g/l
2.20
11
40
13
74
1.79
1.08
1.4
1.4
—
—
—
0
0
9
48
1.90
1.01
1.3
1.3
—
—
—
0
0
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
12
70
1.74
0.93
8.4
5.8
1.2
1.5
mg/l
1.53
12
63
14
86
1.65
0.92
6.6
4.4
3.5
3.9
mmol/l
2.50
14
79
6
28
2.16
0.92
2.0
1.1
—
—
—
0
0
57
472
1.25
0.77
2.7
2.2
2.4
2.4
mmol/l
0.05
49
391
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
14
205
0.67
0.72
5.0
2.4
62.2
60.3
ml/min/173m2
—
6
88
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
2.5
—
150.2
—
0
5
117
1072
1.14
0.51
3.7
3.8
32.7
72.6
ng/l
0.67
90
768
35
414
0.83
0.45
1.2
1.3
14.0
33.5
iu/ml
2.84
12
142
8
56
1.44
0.43
3.1
1.8
11.1
17.6
u/ml
—
8
42
111
1028
1.12
0.41
2.7
2.3
74.5
76.3
nmol/l
0.27
100
893
5
35
1.43
0.39
1.0
1.4
—
—
—
0
0
91
836
1.12
0.38
3.3
2.1
136.4
320.3
u/l
1.15
85
777
33
383
0.85
0.36
1.2
1.3
1.0
12.6
u/ml
—
7
146
36
405
0.88
0.28
20.1
27.8
1.1
1.4
inr
—
7
58
8
65
1.24
0.27
1.3
1.1
—
10.6
—
0
11
65
601
1.10
0.25
1.6
1.8
464.4
11753004.3
pmol/l
0.50
54
485
69
643
1.09
0.23
3.5
4.1
0.0
0.0
estimate
0.00
22
188
10
79
1.27
0.22
1.1
2.2
—
—
—
0
0
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
9.1
—
0
11
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
8
105
0.76
0.21
2.3
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
39
355
1.11
0.21
1.5
1.5
—
—
—
0
0
192
1866
1.06
0.21
5.0
4.1
26.0
12.5
mm/h
10.03
180
1692
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
6
53
1.13
0.19
1.8
1.4
—
—
—
0
0
24
268
0.89
0.18
1.9
1.4
—
—
—
0
0
27
243
1.12
0.18
8.3
3.2
—
—
—
0
0
15
134
1.12
0.11
7.3
2.6
1.4
1.2
%
0.59
15
134
9
85
1.06
0.07
1.7
1.9
—
—
—
0
0
117
1191
0.97
0.06
5.6
5.2
0.0
0.0
estimate
0.00
22
190
34
325
1.05
0.06
3.0
4.9
26.4
32.2
%
2.44
27
204
121
1196
1.02
0.03
3.8
3.8
0.0
0.0
estimate
0.00
24
199
120
1214
0.98
0.03
3.9
3.8
0.0
0.0
estimate
0.00
22
192
94
927
1.02
0.03
3.7
4.0
—
—
—
0
0
153
1518
1.01
0.02
4.9
3.0
66.6
46.9
u/l
1.56
143
1393
33
336
0.98
0.00
14.8
7.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
6
59
1.02
0.00
1.7
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
16.4
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_AML_EXALLC – Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).